Brief: Qlife Receives Order From Statens Serum Institut For Covid-19 Testing
Jan 29 (Reuters) - Qlife Holding AB QLIFE.ST :
* QLIFE RECEIVES ORDER FROM STATENS SERUM INSTITUT FOR
COVID-19
TESTING
* DENMARK'S INFECTIOUS DISEASE AGENCY, STATENS SERUM
INSTITUT, HAS
PLACED AN ORDER OF 50 EGOO
* ORDER REPRESENTS A VALUE OF APPROXIMATELY 1 MDKK, AND
QLIFE
EXPECTS TO COMPLETE DELIVERY IN FEBRUARY 2021
Source text for Eikon: ID:nWkr2x4LrP
Further company coverage: QLIFE.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Qlife Holding AB
See all newsAdvisory: Alerts on Qlife's agreement with global pharma company withdrawn
Brief: Qlife Holding Enters Feasibility Deal With Pharma Co For Egoo Health Biomarker
Brief: Qlife Holding Q1 EBITDA Loss SEK 5.5 Mln
Sweden's Qlife Q1 revenue drops, losses widen slightly
Brief: Qlife Holding Q4 EBITDA At SEK -1.6 Million